Overview

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2017-07-31
Target enrollment:
Participant gender:
Summary
A single-dose, comparative bioavailability study of two formulations of ursodiol 500mg tablets under fasting conditions
Phase:
Phase 1
Details
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Treatments:
Ursodeoxycholic Acid